Loading…

Treatment of Primary Plasma Cell Leukemia with Carfilzomib and Lenalidomide-Based Therapy: Results of the Final Analysis of the Prospective Phase 2 EMN12/HOVON-129 Study for Patients Aged 18-65 Years

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.4420-4422
Main Authors: Van De Donk, Niels W.C.J., Minnema, Monique C., van der Holt, Bronno, Schjesvold, Fredrik, Wu, Ka Lung, Capra, Andrea, Broijl, Annemiek, Roeloffzen, Wilfried W.H., Gadisseur, Alain, Pietrantuono, Giuseppe, Pour, Ludek, van der Velden, Vincent H.J., Lund, Thomas, Offidani, Massimo, Grasso, Mariella, Giaccone, Luisa, Cavo, Michele, Silkjaer, Trine, Caers, Jo, Zweegman, Sonja, Hájek, Roman, Benjamin, Reuben, Vangsted, Annette Juul, Boccadoro, Mario, Gay, Francesca, Sonneveld, Pieter, Musto, Pellegrino
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-165942